4//SEC Filing
Linscott Walt Addison 4
Accession 0001213900-20-027391
CIK 0001638381other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 5:01 PM ET
Size
5.2 KB
Accession
0001213900-20-027391
Insider Transaction Report
Form 4
Linscott Walt Addison
Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2020-09-16+100,000→ 100,000 totalExercise: $0.32Exp: 2027-09-16→ Ordinary Shares (100,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in full on December 31, 2021.
Documents
Issuer
Intec Pharma Ltd.
CIK 0001638381
Entity typeother
Related Parties
1- filerCIK 0001648585
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 5:01 PM ET
- Size
- 5.2 KB